Testosterone-induced increase of insulin-like growth factor I levels depends upon normal levels of growth hormone
Abstract
Pubertal development is associated with a rise in plasma insulin-like growth factor I (IGF-I) levels that is related both to the increase in sex steroids and/or to the sex steroid-induced augmentation in endogenous growth hormone (GH) secretion. In order to investigate the relationship between IGF-I, GH and testosterone, we examined 42 male subjects with various clinical conditions (classical GH deficiency (CGHD, N = 5), non-classical GH deficiency (NCGHD, N = 7), short idiopathic stature (N = 6), nutritional obesity (N = 8), GH-treated CGHD (N = 4), GH-treated NCGHD (N = 5) and normal stature (N = 7)) in which , for evaluation of hypogonadism (i.e. the absence of one or both testes from the scrotal sac), human chorionic gonadotropin (hCG) tests were performed. We measured IGF-I, total and free testosterone and dehydroepiandrosterone sulfate (DHEAS) by radioimmunoassays before and 48 and 96 h after the start of the test. The values of IGF-I were lower (0.001 < p < 0.005) in CGHD and NCGHD than in the other groups. In comparison to basal levels, IGF-I values increased (0.005 < p < 0.05) both 48 and 96 h after the start of the hCG test in short idiopathic and normal stature children and in GH-treated subjects with NCGHD, but only 96 h in subjects with untreated NCGHD and GH-treated CGHD. No difference was demonstrated in basal values of total testosterone among any of the groups, while basal free testosterone levels were higher (0.001 < p < 0.05) in GH-treated subjects with NCGHD than in all the other groups except nutritional obesity; furthermore, free testosterone was higher (p < 0.05) in nutritional obesity than in CGHD. The values of total and free testosterone obtained both 48 and 96 h after the start of the hCG test were higher (0.001 < p < 0.05) than basal values in all groups. The DHEAS values did not show any significant change during the hCG test. Basal values were higher (0.01 < p < 0.05) in nutritional obesity than in the other groups. Considering all groups, chronological age, bone age and bone age/chronological age ratio were correlated with basal free testosterone, IGF-I and DHEAS levels (0.001 < p < 0.05), while basal free testosterone and IGF-I values were correlated with DHEAS levels (p < 0.005 and < 0.01, respectively). In conclusion, our study during the hCG test in boys with various clinical conditions demonstrated an increase in IGF-I concentrations only in those boys with sufficient GH secretion or GH replacement therapy. These findings indicate that both sex steroids and GH are necessary to allow for the pubertal increase in IGF-I levels.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Testosterone amplifies GH stimulation of IGF-I by enhancing GH receptor expression.
“Testosterone stimulates GH secretion centrally and through aromatization to oestrogen, but as opposed to the oestrogen concentration in fertile women, also amplifies GH stimulation of IGF-I by enhancing GH receptor expression (Saggese et al., 1996;Span et al., 2000;Weissberger, 1993;Yu et al., 1996).”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Saggese et al., 1996
Testosterone stimulates GH secretion centrally and through aromatization to oestrogen.
“Testosterone stimulates GH secretion centrally and through aromatization to oestrogen, but as opposed to the oestrogen concentration in fertile women, also amplifies GH stimulation of IGF-I by enhancing GH receptor expression (Saggese et al., 1996;Span et al., 2000;Weissberger, 1993;Yu et al., 1996).”
From The hypothalamus-pituitary-thyroid (HPT)-axis and its role in physiology and pathophysiology of other hypothalamus-pituitary functions (2021) · cites this paper as Saggese et al., 1996
Cited by
Sorted by citations
Feldt-Rasmussen, U., Effraimidis, G., & Klose, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111173 · Cited by 170 · see citing works
Sex steroids and the GH axis: implications for the management of hypopituitarism
Birzniece, V., & Ho, K. K. Y. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.03.003 · Cited by 65 · see citing works
- Authors
- Saggese, G., Cesaretti, G., Franchi, G., & Startari, L.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Saggese, Giuseppe
- ORCID
- Franchi, Giulia
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-08
- Volume
- 135
- Issue
- 2
- Pages
- 211-215
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2093577903
- Cited by
- 16
- References
- 0
- Citations by year
- 2021: 2 · 2020: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- insulin-like growth factor I, testosterone, growth hormone, growth hormone deficiency, pubertal development, hypogonadism, short stature, nutritional obesity, human chorionic gonadotropin stimulation, free testosterone, dehydroepiandrosterone sulfate, sex steroids, children and adolescents, growth hormone replacement therapy, hypogonadotropic hypogonadism
- MeSH terms
- Body Height, Child, Diet, Chorionic Gonadotropin, Growth Disorders, Humans, Hypogonadism, Insulin-Like Growth Factor I, Male, Obesity, Reference Values, Growth Hormone, Testosterone, Dehydroepiandrosterone Sulfate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review